share_log

复星医药:复星医药:国浩律师(上海)事务所关于上海复星医药(集团)股份有限公司2022年限制性A股股票激励计划部分限制性股票回购注销实施情况的法律意见书

Fosun Pharmaceuticals: Fosun Pharmaceuticals: Legal Opinion of Attorney Guo Hao (Shanghai) Office on the implementation of partial restricted stock repurchases and cancellation of the 2022 Restricted A-share Stock Incentive Plan of Shanghai Fosun Pharmaceuticals (Group) Co., Ltd.

SZSI ·  Sep 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more